Prognostische Validierung der laborbasierten 3P/5P-Riskomodelle für portale Hypertension bei kompensierter fortgeschrittener chronischer Lebererkrankung
Gero Kramer(Memorial Sloan Kettering Cancer Center), T Reiberger(Medical University of Vienna), B Simbrunner(Medical University of Vienna), Paul Thöne(Medical University of Vienna), Lukas Hartl(Medical University of Vienna), Jiří Reiniš(Austrian Academy of Sciences), Natalia Dominik(National Hospital for Neurology and Neurosurgery), Philipp Schwabl(Austrian Academy of Sciences), Mattias Mandorfer(Medical University of Vienna), Oleksandr Petrenko(Austrian Academy of Sciences), M Trauner(Medical University of Vienna), Benedikt Hofer(Austrian Academy of Sciences), Albert Friedrich Stättermayer(Medical University of Vienna), Mathias Jachs(Medical University of Vienna), Christian Sebesta(Donauspital), Maria Schwarz(Universitätsklinik für Neurologie), Lorenz Balcar(Medical University of Vienna), G Semmler(Medical University of Vienna)
Cited by 0
Related Papers
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
|European Urology|2017|644
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
|Journal of Hepatology|2021|309
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality
|Journal of Hepatology|2020|202
Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis
|Clinical Gastroenterology and Hepatology|2022|130